Annual report
4564.TEDINET S100W4BQ
Period2024-04-01 → 2025-03-31
Filed2025-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks20 of 20 passed
Key figures · 124
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥750m | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥610m | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Operating income | −¥798m | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | −¥1.1bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | −¥815m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥1.1bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥1.1bn | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥2.1bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.6bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥813m | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥1.3bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥815m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥1.3bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥1.1bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥2.6bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥1.6bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥815m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | −¥1.3bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥1.2bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥867m | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥1.5bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥2.7bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥3.4bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥426m | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥514m | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥729m | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥354m | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥855m | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥2.0bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥3.1bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥834m | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥528m | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥834m | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥528m | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.8bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥2.9bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥815m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.2bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥795m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥2.1bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.8bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥279,000 | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥33m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥20m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥468m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥52m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥1.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥671m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥96m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.5bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-3.12 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.05 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.81 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-13.72 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.86 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2.42 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1.28 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4.04 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥9.84 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥16.96 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 57.0% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.5% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.6% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.8% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Employees | 47 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 54 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 60 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 67 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 66 | at 2021-03-31d | Cons. | Number of employees |
| Operating income | −¥728m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | −¥889m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | −¥712m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥873m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥1.1bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥2.0bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.3bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥814m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥1.0bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | −¥815m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | −¥1.0bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | −¥1.1bn | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥2.4bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥1.5bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥840m | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥507m | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥949m | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.1bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.9bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥111m | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥154m | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥729m | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥354m | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥575m | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥1.7bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥2.6bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥614m | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥325m | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-3.12 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.74 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.8 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-12.94 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.77 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2.42 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1.28 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2.58 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥8.38 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥14.53 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 78.3% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.0% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.4% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.3% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 271,643,700 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 217,643,700 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 192,643,700 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 192,643,700 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 176,332,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 18 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 27 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 28 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 36 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 35 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 43
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥294,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥294,000 |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | −¥107m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥220m |
| Cancer Precision Medical Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥279,000 |
| Cancer Precision Medical Businessreportable segment | employees | at 2025-03-31 | 29 pure |
| Cancer Precision Medical Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥747m |
| Cancer Precision Medical Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥747m |
| Cancer Precision Medical Businessreportable segment | segment assets | at 2025-03-31 | ¥470m |
| Cancer Precision Medical Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥91m |
| Research And Development Of Pharmaceutical Productsreportable segment | employees | at 2025-03-31 | 18 pure |
| Research And Development Of Pharmaceutical Productsreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥3m |
| Research And Development Of Pharmaceutical Productsreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥3m |
| Research And Development Of Pharmaceutical Productsreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥294,000 |
| Research And Development Of Pharmaceutical Productsreportable segment | segment assets | at 2025-03-31 | ¥792m |
| Research And Development Of Pharmaceutical Productsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥487m |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥279,000 |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥750m |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥750m |
| —segment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥294,000 |
| —segment total | segment assets | at 2025-03-31 | ¥1.3bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | −¥578m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2024-03-31 | −¥270,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2024-03-31 | −¥270,000 |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥2m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥211m |
| Cancer Precision Medical Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥155m |
| Cancer Precision Medical Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥610m |
| Cancer Precision Medical Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥610m |
| Cancer Precision Medical Businessreportable segment | segment assets | at 2024-03-31 | ¥407m |
| Cancer Precision Medical Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | −¥236m |
| Research And Development Of Pharmaceutical Productsreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥698,000 |
| Research And Development Of Pharmaceutical Productsreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥427,000 |
| Research And Development Of Pharmaceutical Productsreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥270,000 |
| Research And Development Of Pharmaceutical Productsreportable segment | segment assets | at 2024-03-31 | ¥459m |
| Research And Development Of Pharmaceutical Productsreportable segment | segment profit | 2023-04-01 → 2024-03-31 | −¥675m |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥155m |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥610m |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥610m |
| —segment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥270,000 |
| —segment total | segment assets | at 2024-03-31 | ¥866m |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | −¥910m |
| Research And Development Of Pharmaceutical Productsreportable segment | employees | at 2025-03-31 | 18 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,168
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)やまと監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)南出 浩一 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)木村 喬 | |
| Key audit matters consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)連結子会社と関連当事者との取引 | |
| Description including reason kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Reference kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)【注記事項】【関連当事者情報】 | |
| Auditors response kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Other information consolidated (text) | FilingDateInstant | Text · Plus | |
| Fee related information consolidated (text) | FilingDateInstant | Text · Plus | |
| Independent auditors report non consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)やまと監査法人 | |
| Cpa1 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)南出 浩一 | |
| Cpa2 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)木村 喬 | |
| Key audit matters non consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam non consolidated (text) | FilingDateInstant | Text · Plus | |
| Other information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Fee related information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Number of submission | FilingDateInstant | 1 | |
| Business revenue (5-year summary) | Prior4YearDuration | 332477000 | JPY |
| Business revenue (5-year summary) | Prior3YearDuration | 1153663000 | JPY |
| Business revenue (5-year summary) | Prior2YearDuration | 1134903000 | JPY |
| Business revenue (5-year summary) | Prior1YearDuration | 610118000 | JPY |
| Business revenue (5-year summary) | CurrentYearDuration | 750048000 | JPY |
| Ordinary income loss (5-year summary) | Prior4YearDuration | -1639262000 | JPY |
| Ordinary income loss (5-year summary) | Prior3YearDuration | -2071783000 | JPY |
| Ordinary income loss (5-year summary) | Prior2YearDuration | -1133099000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | -1136373000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYearDuration | -815046000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior4YearDuration | -1561636000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior3YearDuration | -2571541000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior2YearDuration | -1118644000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | -1288138000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYearDuration | -815285000 | JPY |
| Comprehensive income (5-year summary) | Prior4YearDuration | -1561636000 | JPY |
| Comprehensive income (5-year summary) | Prior3YearDuration | -2571541000 | JPY |
| Comprehensive income (5-year summary) | Prior2YearDuration | -1118644000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | -1288138000 | JPY |
| Comprehensive income (5-year summary) | CurrentYearDuration | -815285000 | JPY |
| Net assets (5-year summary) | Prior4YearInstant | 3076822000 | JPY |
| Net assets (5-year summary) | Prior3YearInstant | 1980233000 | JPY |
| Net assets (5-year summary) | Prior2YearInstant | 855169000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 353666000 | JPY |
| Net assets (5-year summary) | CurrentYearInstant | 729111000 | JPY |
| Total assets (5-year summary) | Prior4YearInstant | 3368102000 | JPY |
| Total assets (5-year summary) | Prior3YearInstant | 2685199000 | JPY |
| Total assets (5-year summary) | Prior2YearInstant | 1511438000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 867275000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 20 of 20 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |